-

MEDIA ADVISORY: The Next-Generation Commercial Model – Questions You Should Be Asking

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences:

WHAT: Webinar Targeted to Life Sciences Executives
WHEN: October 11, 2022, 1:00 PM ET
TOPIC: The Next-Generation Commercial Model – Questions You Should Be Asking

Trinity Life Sciences, a global leader in life sciences solutions, today announced it will hold a webinar for executives in the life sciences industry entitled The Next-Generation Commercial Model – Questions You Should Be Asking.

Dramatic shifts in scientific innovation in the life sciences industry have been further accelerated by the COVID-19 pandemic. Despite these shifts, Trinity Life Sciences found that the commercial models employed by companies that launched new products recently were still largely based on traditional sales and marketing approaches.

In reaction to these findings, our experts published a paper entitled Empowering the Next-Generation Launch Model that explored ways in which industry players could elevate and evolve their commercialization approaches to keep pace with the accelerated growth in innovation. In the October 11th webinar, the Trinity team will review key findings in the paper and share lessons learned and actionable strategies based on discussions they have had with dozens of clients.

Presenters will include:

  • Krista Perry, Partner and Head of Launch Excellence at Trinity Life Sciences
  • Susheel Sukhtankar, Partner and Head of Commercial Analytics
  • Curt Staab, Senior Vice President, Emerging Life Sciences Network at TGaS Advisors, a Division of Trinity Life Sciences

Insights from this webinar will surprise you.

“Whether you are an emerging, mid-tier or large-tier company preparing for launch, now is the time to challenge conventional thinking,” said Ms. Perry.

Members of the media can contact Elizabeth Marshall directly for access to the paper or an invite to the webinar.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom